Rozanolixizumab: A New Therapy in the Treatment of Myasthenia Gravis

The aims of this article are to review the clinical aspects of rozanolixizumab, to describe clinical trial results that led to the drug's approval, and to examine the impact on patient care to aid clinical decision making.